These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1025 related articles for article (PubMed ID: 29374557)

  • 1. Molecular Paths Linking Metabolic Diseases, Gut Microbiota Dysbiosis and Enterobacteria Infections.
    Serino M
    J Mol Biol; 2018 Mar; 430(5):581-590. PubMed ID: 29374557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Genotoxin Colibactin Shapes Gut Microbiota in Mice.
    Tronnet S; Floch P; Lucarelli L; Gaillard D; Martin P; Serino M; Oswald E
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32611705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiome Dysbiosis and Immunometabolism: New Frontiers for Treatment of Metabolic Diseases.
    Belizário JE; Faintuch J; Garay-Malpartida M
    Mediators Inflamm; 2018; 2018():2037838. PubMed ID: 30622429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Administration of P. gingivalis Induces Dysbiosis of Gut Microbiota and Impaired Barrier Function Leading to Dissemination of Enterobacteria to the Liver.
    Nakajima M; Arimatsu K; Kato T; Matsuda Y; Minagawa T; Takahashi N; Ohno H; Yamazaki K
    PLoS One; 2015; 10(7):e0134234. PubMed ID: 26218067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Western diets, gut dysbiosis, and metabolic diseases: Are they linked?
    Martinez KB; Leone V; Chang EB
    Gut Microbes; 2017 Mar; 8(2):130-142. PubMed ID: 28059614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of interaction between MicroRNAs and gut microbiota in several pathways.
    Behrouzi A; Ashrafian F; Mazaheri H; Lari A; Nouri M; Riazi Rad F; Hoseini Tavassol Z; Siadat SD
    Microb Pathog; 2020 Jul; 144():104200. PubMed ID: 32289465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Dysbiosis in Animals Due to Environmental Chemical Exposures.
    Rosenfeld CS
    Front Cell Infect Microbiol; 2017; 7():396. PubMed ID: 28936425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diet-microbiota-metabolite axis regulates the host physiology.
    Yamada T; Takahashi D; Hase K
    J Biochem; 2016 Jul; 160(1):1-10. PubMed ID: 26970281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of metabolic potential of human gut microbiome in human nutrition.
    Yadav M; Verma MK; Chauhan NS
    Arch Microbiol; 2018 Mar; 200(2):203-217. PubMed ID: 29188341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Human Gut Microbiota.
    Harmsen HJ; de Goffau MC
    Adv Exp Med Biol; 2016; 902():95-108. PubMed ID: 27161353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiota and Metabolic Disorders: Advances in Therapeutic Interventions.
    Akash MSH; Fiayyaz F; Rehman K; Sabir S; Rasool MH
    Crit Rev Immunol; 2019; 39(4):223-237. PubMed ID: 32421966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The human gut microbiota: Interactions with the host and dysfunctions].
    Lepage P
    Rev Mal Respir; 2017 Dec; 34(10):1085-1090. PubMed ID: 28506730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the gut microbiota on inflammation, obesity, and metabolic disease.
    Boulangé CL; Neves AL; Chilloux J; Nicholson JK; Dumas ME
    Genome Med; 2016 Apr; 8(1):42. PubMed ID: 27098727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome and type 2 diabetes: where we are and where to go?
    Sharma S; Tripathi P
    J Nutr Biochem; 2019 Jan; 63():101-108. PubMed ID: 30366260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-3 polyunsaturated fatty acids: An innovative strategy against obesity and related metabolic disorders, intestinal alteration and gut microbiota dysbiosis.
    Bellenger J; Bellenger S; Escoula Q; Bidu C; Narce M
    Biochimie; 2019 Apr; 159():66-71. PubMed ID: 30690133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential impact of gut microbiota on your health:Current status and future challenges.
    Sirisinha S
    Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.